Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BiO2 Medical

Request full access

Leading commercial-stage developer of innovative vascular devices

San Antonio, United StatesFounded 2006Health Tech & Medtech

About BiO2 Medical

BiO2 Medical, Inc. operates as a commercial-stage medical device company, focusing on developing vascular devices to address unmet clinical needs. Founded in December 2006 by Dr. Luis F. Angel, Christopher E. Banas, and Dr. Paul Castella, the company established its headquarters in San Antonio, Texas, with research, development, and manufacturing facilities in Golden, Colorado. The company's business revolves around the design, manufacturing, and commercialization of its flagship product, the Angel® Catheter. This device is sold to hospitals and medical centers for use with critically ill patients at high risk for pulmonary embolism (PE).

The company's primary product, the Angel® Catheter, is a combination of a central venous catheter (CVC) and an Inferior Vena Cava (IVC) filter. Invented by co-founder Dr. Luis F. Angel, an Associate Professor of Pulmonary and Critical Care Medicine, the device is designed to provide venous access while simultaneously protecting against PE by trapping blood clots. A key feature is that the filter is permanently attached to the catheter, which is designed to ensure its retrieval once it is no longer needed, mitigating risks associated with traditional IVC filters like migration and fracture. The Angel® Catheter is designed for bedside placement without the need for fluoroscopic guidance, streamlining the procedure for intensive care unit (ICU) patients. This approach provides immediate protection for patients for whom anticoagulant therapies may be contraindicated.

BiO2 Medical's history includes several significant funding rounds to support product development and commercialization. The company completed a $13.7M Series B round in March 2012 and secured $12M in a Series C round in September 2012. These funds were crucial for achieving CE Mark approval in Europe in 2012 and advancing through the FDA regulatory process in the U.S. A pivotal milestone was reached in August 2016 when the Angel® Catheter received 510(k) clearance from the FDA, notably including a first-ever prophylactic indication for a device to prevent PE. Subsequently, in August 2018, the Angel Catheter technology and associated intellectual property were acquired by Mermaid Medical Group, a Danish provider of medical devices, which took over supporting the existing customer base with plans for global expansion.

Source: Dealroom company data

At a glance

Status
Closed
Employees
13
Open positions
None listed
Industry
Health
Sub-industry
Medical Devices
Sector
Catheters, Critical medical care, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2C

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Mar 2017 $1.5M — Undisclosed —
DEBT✓Debt Aug 2016 $3M — Oxford Finance —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

BiO2 Medical website traffic

Latest recorded traffic for BiO2 Medical is 200 monthly website visits, up 66.7% over the last three months. BiO2 Medical's team grew 18.2% over the past year.

Latest monthly visits200 3-month web change+66.7% 1-year team growth+18.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Serenno MedicalA medical device company creating a urine-output measuring device for the ICU Yokneam Ilit, Israel Operational 4 $1.5M $6M
Hotspur TechnologiesDeveloper of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels Mountain View, United States Acquired
Liberate MedicalTreating and diagnosing respiratory disease through non-invasive medical devices Crestwood, United States Operational
SensifreeSensifree is focused on developing the future of blood pressure monitoring devices by providing cuff-free, comfortable, and discreet continuous monitoring of this critical vital sign Cupertino, United States Operational
Inovytec Medical SolutionsInnovative solutions for out-of-hospital medical emergencies, enhancing survivability with advanced airway management and portable ventilators Ra'anana, Israel Operational
EchoCare TechnologiesEchoCare Technologies develops non-wearable, self-learning, elder-care home monitoring device that automatically alerts safety and emergency situations Rehovot, Israel Operational
Hip Hope TechnologiesHip Hope Technologies is a start-up company developing a sophisticated active wearable device aimed at real-time protection of seniors from deadly fall-related hip fractures Hod Hasharon, Israel Operational
Intelligent UltrasoundAI-powered ultrasound simulation and image analysis software Cardiff, United Kingdom Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BiO2 Medical in the San Antonio ecosystem

Live from Dealroom

The BiO2 Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Pasadera Capital
  • Targeted Technology Fund
  • Texas Economic Development Corporation

Series B and later2 investors entered at this stage

  • Remeditex Ventures
  • Oxford Finance
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇧🇷 Brazil60%
🇺🇸 United States20%
🇮🇹 Italy20%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BiO2 Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BiO2 Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.